Jeannette M. Watson
Age UK(GB)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Neuroscience and Neuropharmacology Research, Neurotransmitter Receptor Influence on Behavior, Neuropeptides and Animal Physiology, Nicotinic Acetylcholine Receptors Study
Most-Cited Works
- → Muscarinic acetylcholine receptors as CNS drug targets(2007)417 cited
- → Vilazodone: A 5‐HT1AReceptor Agonist/Serotonin Transporter Inhibitor for the Treatment of Affective Disorders(2009)262 cited
- → GPR105, a novel Gi/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: possible role in neuroimmune function(2003)107 cited
- → The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction(2012)102 cited
- → 5‐HT1A receptor agonist‐antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systems(2000)76 cited
- → Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptor.(1996)74 cited
- → Design and Synthesis oftrans-3-(2-(4-((3-(3-(5-Methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro- 1H-3-benzazepine (SB-414796): A Potent and Selective Dopamine D3Receptor Antagonist(2003)72 cited
- → GR127935 acts as a partial agonist at recombinant human 5-HT1Dα and 5-HT1Dβ receptors(1996)65 cited
- → Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry(1999)64 cited
- → Orthosteric and Allosteric Modes of Interaction of Novel Selective Agonists of the M1 Muscarinic Acetylcholine Receptor(2010)64 cited